Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CVRX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
12 top institutions tracked
Sentiment: neutral
Last trade: buy 62 days ago
Red flags: 2
88 filers reported a long position in CVRX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JOHNSON & JOHNSON | $20.7M | 4M | Unchanged |
| NEA Management Company, LLC | $10M | 2M | -3.5% |
| BlackRock, Inc. | $6.4M | 1.2M | +21.3% |
| ROYAL BANK OF CANADA | $6.3M | 1.2M | +74.4% |
| GSK plc | $5.2M | 1M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.7M | 910.6K | -0.1% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $4.5M | 878.1K | +53.5% |
| GEODE CAPITAL MANAGEMENT, LLC | $2.3M | 440.8K | +3.2% |
| PFM Health Sciences, LP | $1.9M | 369.6K | New |
| STATE STREET CORP | $1.9M | 366.4K | +4.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.